
Twist Bioscience Corporation (TWST) – Ready for break-even with positive EPS?
in Company Report , Healthcare & Life Sciences , Pharma & Biotech on December 7, 2022This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for insights on any specific sector/industry and market recommendations.
Twist Bioscience Corporation (TWST)
The company has been alleged to have high cash burning ratio. It is experiencing cash burn issues despite a strong balance sheet.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– Peer Valuation
– Economic Value Analysis
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Segment Performance
– Key Developments
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
CrispIdea Coverage
No of Pages : 29